¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"set point theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
  • null point
    Á¤ÁöÁ¡
  • ossification point
    (¢¡ossification center) »ÀµÇ±âÁß½É, °ñÈ­Áß½É
  • point
    Á¡
  • point prevalence
    ½ÃÁ¡À¯º´À²
  • point sampling
    Á¡ÃßÃâ¹ý
  • reference point
    ±âÁØÁ¡
  • saturation point
    Æ÷È­Á¡
  • tender point
    ¾ÐÅëÁ¡, ´©¸§ÅëÁ¡
  • trigger point
    À¯¹ßÁ¡
  • working point
    ÀÛ¿ëÁ¡
  • two point threshold
    µÎÁ¡½Äº°¹®Åΰª, µÎÁ¡½Äº°¿ªÄ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • resonator theory
    °ø¸í±â¼³
  • resonator theory
    °ø¸í±â¼³(ÍìÙ°Ðïæò).
  • role theory
    ¿ªÇÒÀÌ·Ð(ÊÙËöËÈ).
  • schizoid condition, in Fairbain theory
    ºÐ¿­¼º »óÅÂ(Fairbain À̷п¡¼­ÀÇ)
  • security operation, in Sullivans theory
    ¾ÈÀüÁ¶ÀÛ(¼³¸®¹ÝÀÌ·Ð)
  • selectionist theory
    µµÅ·ÐÀÚ ÀÌ·Ð
  • self-efficacy theory
    ÀÚ±âÀ¯È¿¼ºÀÌ·Ð
  • semiotic function, Piaget theory
    ±âÈ£¾ð¾îÇÐÀû ±â´É(ÇǾÆÁ¦ ÀÌ·Ð)
  • separation theory, of Bowlby
    ºÐ¸®ÀÌ·Ð(º¼ºñÀÇ)
  • side chain theory
    Ç×ü»ý»êÃø¼â¼³
  • signal detection theory
    ½ÅÈ£°¨ÁöÀÌ·Ð
  • sliding theory
    ¹Ì²ô·³¼³, ȰÁÖ¼³.
  • social learning theory
    »çȸÇнÀ°¡¼³
  • social selection theory
    »çȸ¼±Å𡼳
  • social-cognitive learning theory
    »çȸÀÎÁöÇнÀÀÌ·Ð
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Smithie's theory
    ½º¹ÌƼ ÀÌ·Ð(×âÖå)
  • somatic mutation theory
    ü¼¼Æ÷ º¯ÀÌÀÌ·Ð(ô÷á¬øàܨì¶×âÖå)
  • somatic recombination theory
    ü¼¼Æ÷ ÀçÁ¶ÇÕ ÀÌ·Ð(ô÷á¬øàî¢ðÚùê×âÖå)
  • somatic theory
    ü¼¼Æ÷ ÀÌ·Ð(ô÷á¬øà×âÖå)
  • specific interaction theory
    ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
  • stereochemical theory
    ÀÔüȭÇÐ ÀÌ·Ð (Ø¡ô÷ûùùÊ×âÖå)
  • Sterzl theory
    ½ºÅÍÁñ ÀÌ·Ð (×âÖå)
  • target theory
    Ç¥ÀûÀÌ·Ð (øöîÜ×âÖå)
  • template theory
    ƲÀÌ·Ð (ìµÖå)
  • theory
    ÀÌ·Ð(×âÖå)
  • theory of absolute reaction rates
    Àý´ë¹ÝÀÀ¼Óµµ ÀÌ·Ð (ï¾ÓßÚãëëáÜÓøì¶Öå)
  • theory of antibody formation
    Ç×üÇü¼º ÀÌ·Ð (ù÷ô÷û¡à÷×âÖå)
  • transition state theory
    õÀÌ »óÅ ÀÌ·Ð(ôÃì¹ßÒ÷¾×âÖå)
  • valence bond theory
    ¿øÀÚ°¡ °áÇÕ(ê«í­Ê¤ Ì¿ùê) ÀÌ·Ð(×âÖå)
  • virogene theory
    ¹ÙÀÌ·¯½ºÀ¯ÀüÀÚ ÀÌ·Ð(×âÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
RIP Respiratory Inversion Point
ad naus to the point of producing nausea [Lat. ad nauseam]
ap anteroposterior; attachment point
bb Bolton point; both bones
Bo Bolton point
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
I.P. isoelectric point
LIP lower inflection point
mbr major break point region
P.I. point
TP tender point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • posterior focal point
    ÈÄ ÃÊÁ¡
  • posterior reference point
    ÈĹæ Âü°íÁ¡
  • round body tapered point
    ȯħ
  • satellate trigger point
    À§¼º ¹ßÅëÁ¡
  • satellite trigger point
    À§¼º ¹ßÅëÁ¡
  • silver point
    ÀºÁ¡
    ±¹Á¦ ¿Âµµ°è¿¡¼­ ÀºÀÇ ¾×»ó°ú °í»óÀÌ ÆòÇü »óŸ¦ ÀÌ·ç´Â ¿Âµµ·Î 960.8¡ÉÀÌ´Ù.
  • specific tender point site
    ƯÁ¤ ¾ÐÅëÁ¡
  • sulfur point
    Ȳ ºñÁ¡
  • supraauricular point
    ÀÌ»óÁ¡
  • tender point
    ¾ÐÅëÁ¡
    ·ù¸¶Æ¼ÁòÇп¡¼­ »ç¿ëµÇ´Â ¿ë¾î·Î¼­ ƯÀÌÇÏ°Ô ¼¶À¯ ±ÙÅë¿¡¼­ ÃËÁø¿¡ ´ëÇØ ÅëÁõÀ» ³ªÅ¸³¾ ¼ö ÀÖ´Â 9½ÖÀÇ ÇØºÎÇÐÀû À§Ä¡
  • trapezius trigger point
    ½Â¸ð±Ù ¹ßÅëÁ¡
  • trigger point
    ¹ßÅëÁ¡, À¯¹ßÁ¡
    ÀÚ±ØÀ» ¹ÞÀ¸¸é ¹Ýº¹ÀûÀ¸·Î ±Þ¼º ½Å°æÅ뼺 ÅëÁõÀ̳ª ÀüÀÌµÈ ±Ù°ñ°Ý¼º ÅëÁõÀ» À¯¹ßÇÏ´Â ÇǺγª ±ÙÀ°ÀÇ ¸ðµç ºÎÀ§ÀÌ´Ù. ÀÌ ¿ë¾î´Â 3Â÷ ½Å°æÅëÀ̳ª ±Ù¸· ÅëÁõ ¸ðµÎ¿¡¼­ »ç¿ëµÈ´Ù. myofascial trigger
  • trigger point injection
    ¹ßÅëÁ¡ ÁÖ»ç
  • trigger point pain
    ¹ßÅëÁ¡ µ¿Åë
  • triple point
    »ïÁß Á¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
incisal point The point located between the incisal edges of the lower central incisors; the graphic projection of the excursions of the incisal point in certain planes is generally used to illustrate the envelope of motion of mandibular movement.
(05 Mar 2000)
isoelectric point <biochemistry> The pH at which a protein carries no net charge. Below the isoelectric point proteins carry a net positive charge, above it a net negative charge. Due to a preponderance of weakly acid residues in almost all proteins, they are nearly all negatively charged at neutral pH. The isoelectric point is of significance in protein purification because it is the pH at which solubility is often minimal and at which mobility in an electrofocusing system is zero (and therefore the point at which the protein will accumulate).
(18 Nov 1997)
isoionic point The pH at which a zwitterion has an equal number of positive and negative charges; in water and in the absence of other solutes, this is the isoelectric point.
(05 Mar 2000)
isosbestic point <physics> In applied spectroscopy, a wavelength at which absorbance of two substances, one of which can be converted into the other, is the same.
(05 Mar 2000)
occipital point The most prominent posterior point on the occipital bone above the inion.
(05 Mar 2000)
o-point <physics> Place where the poloidal magnetic field vanishes in such a way that the nearby flux surfaces are elliptical, for example on the magnetic axis or at the centre of a magnetic island. (See also X-Point.)
(09 Oct 1997)
end point <chemistry> It is the completion point during a titration reaction where there are equal amounts of titrant and whatever is being titrated. It is usually evident by the first perceptible alteration of the colour of an added indicator.
<immunology> It is the most dilute an antibody or antiserum solution can be while still detectably reacting with the antigen.
<statistics> A category of data used to compare the outcome in different arms of a clinical trial. Common endpoints are severe toxicity, disease progression or fall in such surrogate markers as CD4 count, but sometimes death is used as an endpoint.
(08 Mar 2000)
end-point measurement Analytical measurement at the end of a chemical reaction, as opposed to making the measurement while the reaction proceeds.
(05 Mar 2000)
end-point nystagmus A jerky, physiologic nystagmus occurring in a normal individual when attempts are made to fixate a point at the limits of the field of fixation.
Synonym: deviational nystagmus.
(05 Mar 2000)
trigger point A specific point or area where, if stimulated by touch, pain, or pressure, a painful response will be induced.
Synonym: dolorogenic zone, trigger area, trigger zone.
(05 Mar 2000)
triple point The temperature at which all three phases (i.e., solid, liquid, and gas) are in equilibrium; the triple point of water (273.16 K) is a fundamental fixed point in temperature scales.
(05 Mar 2000)
equivalence point In a precipitin reaction, the zone in which neither antibody nor antigen is in excess.
See: precipitation.
Synonym: equivalence point.
(05 Mar 2000)
Trousseau's point A painful point, in neuralgia, at the spinous process of the vertebra below which arises the offending nerve.
Synonym: apophysary point, apophysial point.
(05 Mar 2000)
exclamation point hair <clinical sign> The type of dystrophic anagen hair found at margins of patches of alopecia areata. The bulb is absent.
(21 Jun 2000)
J point The point marking the end of the QRS complex and the beginning of the S or T wave in the electrocardiogram.
Synonym: ST junction.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • focal point
    ÃÊÁ¡
  • four point stance
    4Á¡ ½ºÅĽº
  • freezing point
    ºùÁ¡
  • full point
    Á¾ÁöºÎ
  • fusion point
    À¶Á¡;¿ëÇØÁ¡
  • game point
    (Å״Ͻº µîÀÇ)°ÔÀÓ Æ÷ÀÎÆ®(ÇÑ °ÔÀÓÀÇ ½Â¸®¸¦ °áÁ¤ÇÏ´Â Á¡¼ö)
  • gold point
    Á¤È­ ¼ö¼ÛÁ¡
  • grade point
    (¹Ì)(¼ýÀÚ·Î ³ªÅ¸³½)¼ºÀû ÆòÁ¡
  • grade point average
    (¹Ì)¼ºÀûÀÇ Æò±ÕÁ¡
  • growing point
    »ýÀåÁ¡
  • high point
    Áß´ëÇÑ ½ÃÁ¡;ÃÖ°íÀÇ ½Ã±â
  • ice point
    ºùÁ¡
  • infection point
    º¯°îÁ¡
  • isolated point
    (¼ö)°í¸³Á¡
  • key point
    ¿äÃæ;¿äÁ¡;°ü°Ç !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á